$18.97
-0.25 (-1.30%)
As of Nov 5, 9:44 PM ET ·
Analyst Consensus
Buy
18
Analysts
High
Coverage
Buy 12 67%
Hold 5 28%
Sell 1 6%
Price Target
Analyst Price Target +547.4% upside
Low Target $69.38
Average Target $122.82
High Target $167.78
Current Price $18.97
Current
$18.97
Target
$122.82
$69.38 $122.82 avg $167.78
Scenario Analysis
Bear Case
$69.38
265.7%
Low target
Base Case
$122.82
+547.4%
Avg target
Bull Case
$167.78
+784.4%
High target
Risk/Reward
3.0x
Favorable
Price in Context
52-Week High
$19.23
-1.4% from high
52-Week Low
$9.92
+91.2% from low
50-Day SMA
$17.60
+7.8% vs SMA
200-Day SMA
$15.99
+18.6% vs SMA
RSI (14)
61.8
Neutral
Target vs 52W High
$122.82
+538.7% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -2.5%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +10.0%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.4%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +13.5%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +176.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.3%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +155.6%